Epidemiology of Gunshot Wounds Injuries Admitted in ICU in France (GSW_in_ICU)

January 25, 2022 updated by: Centre Hospitalier Universitaire de Nīmes

Epidemiology of Gunshot Wounds Injuries Admitted in Intensive Care Unit in France: a Retrospective Multicenter Observational Study

In civilian practice, the incidence of firearm violence depends on the country. In high income countries, most cases are reported in the USA or South Africa. In these countries, gunshot wounds (GSW) represent 20% of death cases in trauma centers, more than motor vehicle collisions.

The mortality in civilian practice occurs during the first 24 hours following GSW, mainly due to hemorrhage and traumatic brain injury, though long term effects on physical and psychological outcomes have also been shown.

Some factors of mortality specific to GSW have been established: multiples wounds, homicide vs suicide attempt, impact zone, or firearm caliber.

Few specific guidelines have been published concerning civilian GSW management. These cases are mostly treated in standard guidelines, such as hemorrhagic shock or traumatic brain injury guidelines. As in other trauma mechanisms, the "platinum ten minutes and golden hour" concept is applicable.

In Europe, the incidence of civilian GSW is much lower and few European studies have been published recently. Penetrating injuries in Europe are less likely to be GSW, and are more often self-inflicted than in the USA. In addition, European studies are heterogeneous, due to the difference in populations, healthcare systems and GSW being grouped with stabbing wounds under the label "penetrating trauma".

However, there is a global concern in Europe regarding a potential rise of GSW, with higher severity score than conventional trauma patients and often necessitate ICU admission. Studies analyzing data from different European countries show significantly different ICU admission rates for overall GSW, ranging from 17% up to 30%.

Therefore, the investigators conducted a multicenter, retrospective study on four French University Hospitals aiming to describe the epidemiology (mortality and type of organ damage) and identify prognosis factors of civilian GSW admitted in ICU.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nimes, France, 30029
        • CHU de Nimes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients who were admitted for gunshot wound care in ICU between 1st of January 2015 and June 30th 2021 at Nîmes University Hospital, Marseille North University Hospital, Montpellier DAR_A University Hospital, Toulon Military Teaching Hospital.

Description

Inclusion Criteria:

  • Admission for gunshot wound care in ICU between 1st of January 2015 and June 30th 2021 at Nimes University Hospital, Marseille North University Hospital, Montpellier University Hospital, Toulon Military Teaching Hospital.
  • Patient ≥ 15 years old

Exclusion Criteria:

  • Patient < 15 years old
  • Patient who objected to the use of their data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Gunshot wounds admitted in ICU
patient with Gunshot wounds admitted to ICU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: day 28
mortality rate at day 28 of patients admitted for Gunshot wounds
day 28

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Day 0
To identify if age is a prognosis factors of mortality of patients admitted for Gunshot
Day 0
Sex
Time Frame: Day 0
To identify if sex is a prognosis factors of mortality of patients admitted for Gunshot
Day 0
Comorbidity
Time Frame: Day 0
To identify if some comorbidities are some prognosis factors of mortality of patients admitted for Gunshot wounds (age, sex, comorbidity, type of gunshot, bullet impact zone, delay to reach hospital, biological parameters at ICU admission, use of antibiotics, blood transfusion, type of surgery, medical management, initiation of renal replacement therapy, length of ICU stay, ).
Day 0
Type of gunshot
Time Frame: Day 0
To identify if the type of gunshot is prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0
Bullet impact zone
Time Frame: Day 0
To identify if the impact zone is a prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0
Delay to reach hospital
Time Frame: Day 0
To identify if the delay to reach hospital is a prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0
biological parameters at ICU admission
Time Frame: Day 0
To identify if some biological parameters at admission are prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0
antibiotics cure
Time Frame: Day 0
To identify if an antibiotic cure at admission is a prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0
Blood transfusion
Time Frame: Day 0 to day 30
To identify if a blood transfusion is a prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0 to day 30
Type of surgery
Time Frame: Day 0 to day 30
To identify if surgery type is a prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0 to day 30
renal replacement therapy
Time Frame: Day 0 to day 30
To identify if initiation of renal replacement therapy is a prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0 to day 30
length of ICU stay
Time Frame: Day 0 to day 30
To identify if length of ICU stay is a prognosis factors of mortality of patients admitted for Gunshot wounds
Day 0 to day 30

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Loic ROUGERIE, CHU Nimes
  • Study Director: Laurent MULLER, Md, PhD, CHU Nimes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

August 16, 2021

First Submitted That Met QC Criteria

January 25, 2022

First Posted (Actual)

February 4, 2022

Study Record Updates

Last Update Posted (Actual)

February 4, 2022

Last Update Submitted That Met QC Criteria

January 25, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • LOCAL/2021/LR-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gunshot Wound

3
Subscribe